CA-GLOBALITY
20.12.2022 14:01:34 CET | Business Wire | Press release
Globality, the leader in using artificial intelligence and natural language processing (NLP) to transform the procurement function, today announced it has been named by The AI Journal as the winner of the Best Use of NLP in the 2022 Global Excellence Awards.
This was the biggest year yet for the awards program with more than 250 entries being submitted from across the world. Each entry was reviewed by a 28-person judging panel from across the world with the winner being selected by achieving the highest score. This year the judging panel included representatives from industry dominating brands such as HSBC, Google, Deloitte, Microsoft, and Amazon.
Powered by cutting-edge AI technology, Globality reinvents the procurement process by automating the demand creation, supplier identification, proposal evaluation, and statement of work (SOW) creation process – completely replacing the traditional, outdated Request for Proposal. Its self-service, consumer-like interface uses NLP and machine learning to understand buyers' needs and match companies with suppliers that best meet specific project requirements, all while achieving substantial cost savings and reducing operating expenses.
“We are proud to be recognized by The AI Journal and receive the prestigious Global Excellence Award for Best Use of NLP,” said Lior Delgo, Globality Co-Founder and President. “It reflects the growth and success of Globality’s game-changing AI-powered technology that is helping industry-leading companies such as BT and Santander transform their buying models to manage their company’s spend more efficiently than ever before.
“In today's economic climate especially, sourcing more intelligently and effectively is not just critical to protecting the bottom line, it is key to driving better business outcomes which is exactly what Globality’s technology is empowering our customers to do.”
“Globality has set a high standard for innovation and creativity with its winning entry in the category Best Use of NLP. With this being the biggest year yet, it made the competition for being a finalist tough with innovative, smart, thought-provoking, results-driven entries coming in from companies of all sizes. It is fantastic to see the effort and passion be rewarded by getting the global recognition by winning at the 2022 Global Excellence Awards,” said Tom Allen, Founder and CEO of The AI Journal.
About Globality – Option 1
Globality is the leader in using leading-edge, artificial intelligence-powered technology to dramatically increase cost savings and improve business outcomes that procurement facilitates. Globality’s state-of-the-art digital solution replaces the traditional, outdated Request for Proposal, efficiently and effectively scoping needs, and matches companies with the suppliers that best meet the specific project requirements. By using Globality’s platform, companies achieve substantial cost savings and reduced operating expenses, while also delighting business stakeholders, fostering collaboration, and improving outcomes. For more information, visit www.globality.com
About The AI Journal Global Excellence Awards
The AI Journal’s Global Excellence Awards is a program that recognizes best practices, use cases, campaigns, and exceptional talent from high-performing teams and individuals from companies of all sizes around the world.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005034/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom